29 results
6-K
EX-99.7
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
the YTD total for new prescribers to 89
Continued engagement with broad group of endocrinologists during the quarter through in person calls and presence
6-K
EX-99.1
AMYT
Amryt Pharma Plc
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
with their instructions, at the AGM.
AGM - Listen-Live Facility: To support engagement with our Shareholders, a listen-live telephone facility
6-K
EX-99.2
AMYT
Amryt Pharma Plc
13 Sep 21
Current report (foreign)
8:48am
OF TREATMENT IN SEVERE EB* 49 Preparing for Launch Dedicated expert medical affairs team in field Early payer engagement Dedicated dermatology commercial
424B3
js81tqvg
1 Jul 21
Prospectus supplement
5:20pm
F-4/A
zqyorvwel17
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
424B3
t2f5epl983n p169c6
28 Jun 21
Prospectus supplement
9:18am
424B3
x4qm0y2619oem 1pj3
28 Jun 21
Prospectus supplement
9:17am
6-K
EX-99.1
svy4vp0b hq1w8r7ql
28 Jun 21
Current report (foreign)
9:16am
F-4
rvxner06 2g69
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
gus9l1rvbs6i wlowy
2 Jun 21
Prospectus supplement
10:10am
424B3
gk4j0i5q 3hty
2 Jun 21
Prospectus supplement
10:09am
20-F
zjs9 ys4ox
30 Apr 21
Annual report (foreign)
12:53pm
6-K
EX-99.3
14b cisx4v565lmp
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.1
7iyil
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-10.1
3orsqclcq
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
siwfo
3 Nov 20
Current report (foreign)
8:45am
6-K
EX-99.1
wxuro9gkijz
29 Oct 20
Amryt Announces Positive Results from Phase 3 Trial of Filsuvez® In Epidermolysis Bullosa
8:00am
F-1/A
EX-10.13
d6v7pd1k84k10ddft4
6 Jul 20
Registration statement (foreign) (amended)
5:28pm